Genetic Diversity and Antimicrobial Drug Resistance of Serotype VI Group B Streptococcus, Canada

Two genetically dissimilar sequence type 1 clades dominate the serotype VI group B Streptococcus population of strains causing invasive disease in Canada. Isolates of this rare serotype, recovered mainly from adult patients, were all susceptible to penicillin and vancomycin. However, we observed res...

Descripción completa

Detalles Bibliográficos
Autores principales: Neemuchwala, Alefiya, Teatero, Sarah, Liang, Lindsay, Martin, Irene, Demzcuk, Walter, McGeer, Allison, Fittipaldi, Nahuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2018
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154151/
https://www.ncbi.nlm.nih.gov/pubmed/30226176
http://dx.doi.org/10.3201/eid2410.171711
_version_ 1783357647347515392
author Neemuchwala, Alefiya
Teatero, Sarah
Liang, Lindsay
Martin, Irene
Demzcuk, Walter
McGeer, Allison
Fittipaldi, Nahuel
author_facet Neemuchwala, Alefiya
Teatero, Sarah
Liang, Lindsay
Martin, Irene
Demzcuk, Walter
McGeer, Allison
Fittipaldi, Nahuel
author_sort Neemuchwala, Alefiya
collection PubMed
description Two genetically dissimilar sequence type 1 clades dominate the serotype VI group B Streptococcus population of strains causing invasive disease in Canada. Isolates of this rare serotype, recovered mainly from adult patients, were all susceptible to penicillin and vancomycin. However, we observed resistance to erythromycin and clindamycin.
format Online
Article
Text
id pubmed-6154151
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-61541512018-10-01 Genetic Diversity and Antimicrobial Drug Resistance of Serotype VI Group B Streptococcus, Canada Neemuchwala, Alefiya Teatero, Sarah Liang, Lindsay Martin, Irene Demzcuk, Walter McGeer, Allison Fittipaldi, Nahuel Emerg Infect Dis Research Letter Two genetically dissimilar sequence type 1 clades dominate the serotype VI group B Streptococcus population of strains causing invasive disease in Canada. Isolates of this rare serotype, recovered mainly from adult patients, were all susceptible to penicillin and vancomycin. However, we observed resistance to erythromycin and clindamycin. Centers for Disease Control and Prevention 2018-10 /pmc/articles/PMC6154151/ /pubmed/30226176 http://dx.doi.org/10.3201/eid2410.171711 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research Letter
Neemuchwala, Alefiya
Teatero, Sarah
Liang, Lindsay
Martin, Irene
Demzcuk, Walter
McGeer, Allison
Fittipaldi, Nahuel
Genetic Diversity and Antimicrobial Drug Resistance of Serotype VI Group B Streptococcus, Canada
title Genetic Diversity and Antimicrobial Drug Resistance of Serotype VI Group B Streptococcus, Canada
title_full Genetic Diversity and Antimicrobial Drug Resistance of Serotype VI Group B Streptococcus, Canada
title_fullStr Genetic Diversity and Antimicrobial Drug Resistance of Serotype VI Group B Streptococcus, Canada
title_full_unstemmed Genetic Diversity and Antimicrobial Drug Resistance of Serotype VI Group B Streptococcus, Canada
title_short Genetic Diversity and Antimicrobial Drug Resistance of Serotype VI Group B Streptococcus, Canada
title_sort genetic diversity and antimicrobial drug resistance of serotype vi group b streptococcus, canada
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154151/
https://www.ncbi.nlm.nih.gov/pubmed/30226176
http://dx.doi.org/10.3201/eid2410.171711
work_keys_str_mv AT neemuchwalaalefiya geneticdiversityandantimicrobialdrugresistanceofserotypevigroupbstreptococcuscanada
AT teaterosarah geneticdiversityandantimicrobialdrugresistanceofserotypevigroupbstreptococcuscanada
AT lianglindsay geneticdiversityandantimicrobialdrugresistanceofserotypevigroupbstreptococcuscanada
AT martinirene geneticdiversityandantimicrobialdrugresistanceofserotypevigroupbstreptococcuscanada
AT demzcukwalter geneticdiversityandantimicrobialdrugresistanceofserotypevigroupbstreptococcuscanada
AT mcgeerallison geneticdiversityandantimicrobialdrugresistanceofserotypevigroupbstreptococcuscanada
AT fittipaldinahuel geneticdiversityandantimicrobialdrugresistanceofserotypevigroupbstreptococcuscanada

Ejemplares similares